We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
-12.26%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$19B
AUM Growth
-$3.13B
Cap. Flow
-$232M
Cap. Flow %
-1.22%
Top 10 Hldgs %
15.64%
Holding
2,990
New
179
Increased
1,185
Reduced
1,102
Closed
425

Sector Composition

Rank Sector Weight
1 Technology 8.84%
2 Financials 7.59%
3 Healthcare 7.23%
4 Consumer Discretionary 4.71%
5 Industrials 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
2476
CALL
Verizon
VZ
$196B
$41K ﹤0.01%
10,100
-4,200
-29% -$238K
LYG icon
2477
Lloyds Banking Group
LYG
$88.5B
$40K ﹤0.01%
15,587
-8,570
-35% -$24.4K
MNKD icon
2478
MannKind Corp
MNKD
$1.23B
$40K ﹤0.01%
37,667
+100
+0.3% +$170
JCP
2479
DELISTED
J.C. Penney Company, Inc.
JCP
$40K ﹤0.01%
38,407
+23,287
+154% +$32.7K
CBL
2480
DELISTED
CBL& Associates Properties, Inc.
CBL
$39K ﹤0.01%
20,527
-1,427
-6% -$4.18K
STRM
2481
DELISTED
Streamline Health Solutions
STRM
$38K ﹤0.01%
3,095
AMR
2482
DELISTED
Alta Mesa Resources Inc
AMR
$38K ﹤0.01%
+37,720
New +$95.5K
MIND icon
2483
MIND Technology
MIND
$43.9M
$37K ﹤0.01%
1,436
APRN
2484
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$36K ﹤0.01%
198
-22
-10% -$4.67K
NMM icon
2485
Navios Maritime Partners
NMM
$2.23B
$35K ﹤0.01%
2,784
+17
+0.6% +$348
CGEN icon
2486
Compugen
CGEN
$227M
$33K ﹤0.01%
15,201
+194
+1% +$615
VERU icon
2487
Veru
VERU
$44.8M
$32K ﹤0.01%
2,308
DMK
2488
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$32K ﹤0.01%
205
-83
-29% -$15.9K
LCTX icon
2489
Lineage Cell Therapeutics
LCTX
$283M
$31K ﹤0.01%
33,685
-39,833
-54% -$61K
BGMS
2490
Bio Green Med Solution Inc
BGMS
$4.97M
$30K ﹤0.01%
1
KWY
2491
Kingsway Corp
KWY
$282M
$30K ﹤0.01%
10,400
-2,000
-16% -$4.98K
RMTI icon
2492
Rockwell Medical
RMTI
$27.9M
$30K ﹤0.01%
123
-14
-10% -$5.57K
XXII
2493
22nd Century Group
XXII
$1.52M
0
HTGM
2494
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$29K ﹤0.01%
+64
New +$39.7K
STNG icon
2495
Scorpio Tankers
STNG
$3.72B
$28K ﹤0.01%
1,573
+414
+36% +$7.71K
ASNA
2496
DELISTED
Ascena Retail Group, Inc.
ASNA
$28K ﹤0.01%
553
CVRS
2497
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$28K ﹤0.01%
33,100
+4,000
+14% +$4.77K
PDS
2498
Precision Drilling
PDS
$1.07B
$27K ﹤0.01%
767
-1,562
-67% -$77.4K
GV
2499
DELISTED
Goldfield Corporation
GV
$27K ﹤0.01%
11,899
AVEO
2500
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$27K ﹤0.01%
+1,682
New +$37K

Similar funds

Raymond James Financial Services Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James Financial Services Advisors held 2,990 positions worth $19B, down 14% from $22.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James Financial Services Advisors's Q4 2018 filing shows 179 new, 1,185 increased, 1,102 reduced and 425 closed positions. Its largest new stake was Linde: 66,232 shares worth $10.5M. The largest sale was iShares Core S&P Small-Cap ETF, an estimated $244M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, down from 9.2% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q4 2018 buy was Linde: 66,232 shares worth $10.5M.
  • Raymond James Financial Services Advisors added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $66.8M increase.
  • Raymond James Financial Services Advisors's biggest Q4 2018 reduction was Oracle, cutting an estimated $51.3M.
  • Raymond James Financial Services Advisors fully exited iShares Core S&P Small-Cap ETF in Q4 2018, selling an estimated $244M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 16% of its $19B portfolio in Q4 2018.
  • Raymond James Financial Services Advisors opened 179 new positions and closed 425 in Q4 2018.
  • Raymond James Financial Services Advisors's portfolio value fell 14% quarter-over-quarter to $19B.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.